Target intelligence / Profile preview

Interferon lambda 3 pseudogene 1 (IFNL3P1)

Target
IFNL3P1
Molecular classification
Pseudogene
01

Overview

Interferon lambda 3 pseudogene 1 (IFNL3P1) is a non-protein-coding genomic sequence classified as a pseudogene related to the functional IFNL3 (interferon lambda 3) gene. Pseudogenes are DNA sequences that resemble genes but are nonfunctional due to mutations, truncations, or lack of regulatory elements required for expression. IFNL3P1 does not produce an active protein and has no recognized physiological, pharmacological, or pathological function[1]. Unlike the functional IFNL3 gene, which codes for a cytokine involved in the antiviral immune response, IFNL3P1 does not participate in signaling, disease, or serve as a therapeutic target[1]. Key points: - IFNL3P1 is a pseudogene, not a protein-coding gene, receptor, or therapeutic target[1]. - It should not be considered in the same functional or clinical context as the true IFNL3 (interferon lambda 3). - There are no known aliases, molecular functions, or disease associations for IFNL3P1. - Its status as a pseudogene means it is not the subject of drug targeting, biomarker development, or safety evaluations. This entry is not a therapeutic or drug target; the functional, clinically relevant target is the interferon lambda 3 (IFNL3, IL28B) cytokine, not its pseudogene[2][3][4][5].

Other names
IFN-λ3 pseudogene 1
02

Mechanism of action

Not applicable

Beyond the preview

Go deeper on Interferon lambda 3 pseudogene 1 (IFNL3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interferon lambda 3 pseudogene 1 (IFNL3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call